2026– date –
-
Cellforce One Clinic Tokyo Establishes ‘Cell Processing Governance’ Under Japan’s Regenerative Medicine Law, Offers MSC Therapies for Chronic Pain and Osteoarthritis
Cellforce One Clinic Tokyo Japan Overview Cellforce One Clinic Tokyo, offering integrated regenerative, preventive medicine, and precision imaging, announced the establishment of its 'Cell Processing Governance' in 2026, fully compliant ... -
Syntax Bio & Applied StemCell Partner to Accelerate Allogeneic iPSC Therapies with Low-Immunogenicity Lines and Cellgorithm Platform
Manufacturing Chemist USA Overview Syntax Bio and Applied StemCell have formed a strategic partnership to accelerate programmable iPSC therapy development. This collaboration aims to address key challenges of immune recognition and manuf... -
Japan Leads Global Ophthalmic Regenerative Medicine with First iPSC Retinal Transplant and Cultured Corneas, Backed by Proactive Regulation
Ophthoagent Japan Overview Japan has cemented its global leadership in advanced ophthalmic regenerative medicine, achieving groundbreaking clinical successes such as the world's first iPSC-derived retinal transplant in 2014 and successfu... -
BioInsights Reports >95% T-Cell Recovery with Closed-Loop Centrifugation, Streamlining Cell Therapy Workflows
BioInsights Global Overview The development of flexible, closed, end-to-end cell therapy manufacturing process workflows is progressing, with the Gibco™ CTS™ Rotea™ Counterflow Centrifugation System demonstrating over 95% primary activat... -
Thermo Fisher Scientific Unveils DynaXS Single-Use Bioreactor and Global Manufacturing Expansion at BIO 2026, Boosting Cell & Gene Therapy Production
Business Wire USA Overview Thermo Fisher Scientific announced significant new manufacturing capabilities and AI-enabled research advancements at BIO International 2026, aiming to strengthen the cell and gene therapy sector. Key highlight... -
SK pharmteco Unveils SKyvec™ Viral Vector Platform, Boosting AAV Productivity by 5-6 Fold for Gene Therapy Development
Contract Pharma Global Overview SK pharmteco has launched its innovative 'SKyvec™ Viral Vector Platform,' designed to accelerate gene therapy development. This platform supports adeno-associated virus (AAV), lentivirus, and adenovirus ve... -
iPSC-Derived Immune Cells Pave Way for Scalable Allogeneic T-Cell Therapy Platforms in Cancer Immunotherapy
MDPI Global Overview Allogeneic T-cell therapies are rapidly advancing as a promising strategy in cancer immunotherapy to overcome the logistical and manufacturing challenges inherent in autologous approaches. Crucially, induced pluripot... -
Japan Launches Akougo (Vandefitemcel): A Groundbreaking Cell Therapy Revolutionizing Chronic Motor Impairment Post-TBI
Reddit (引用元: 日刊工業新聞) Japan Overview SanBio has introduced Akougo (Vandefitemcel) in Japan, a pioneering cell therapy designed to address chronic motor impairment following traumatic brain injury (TBI). This innovative regenerati... -
Advanced Culture Media for Cellular Agriculture: Serum-Free & Chemically Defined Formulations Boost Reproducibility, Reduce Contamination
PatSnap Eureka Global Overview Optimizing culture media for cellular agriculture is paramount for its commercial viability, with a significant shift towards serum-free and chemically defined formulations that maintain cell viability and ... -
Matica Bio Unveils ‘Accelerated Korea IIT Platform’ to Fast-Track Cell & Gene Therapy Development with US-Korea Synergy
PR Newswire South Korea Overview Matica Biotechnology (Matica Bio) has launched its 'Accelerated Matica Korea IIT Integrated Platform Solution,' a strategic initiative in collaboration with South Korean clinical networks to expedite Inve...
